Showing results (1-10 of 413) with videos related to
Sort By:
Pageof 42
Thrombosis and Haemostasis|July 1, 1997
Postmenopausal hormone replacement therapy and cardiovascular diseaseC U Chae, P M Ridker, J E MansonHypertension (Dallas, Tex. : 1979)|September 22, 2001
Blood pressure and inflammation in apparently healthy menC U Chae, R T Lee, N Rifai, et al.JAMA|July 24, 2001
C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitusA D Pradhan, J E Manson, N Rifai, et al.Journal of the American College of Cardiology|November 3, 2001
A prospective evaluation of lipoprotein-associated phospholipase A(2) levels and the risk of future cardiovascular events in womenG J Blake, N Dada, J C Fox, et al.Circulation|August 18, 1999
Hormone replacement therapy and increased plasma concentration of C-reactive proteinP M Ridker, C H Hennekens, N Rifai, et al.Archives of Internal Medicine|January 27, 2000
Male pattern baldness and coronary heart disease: the Physicians' Health StudyP A Lotufo, C U Chae, U A Ajani, et al.Circulation|August 1, 1991
Clinical characteristics of nonfatal myocardial infarction among individuals on prophylactic low-dose aspirin therapyP M Ridker, J E Manson, J E Buring, et al.American Heart Journal|December 1, 1991
The effect of chronic platelet inhibition with low-dose aspirin on atherosclerotic progression and acute thrombosis: clinical evidence from the Physicians' Health StudyP M Ridker, J E Manson, J E Buring, et al.Circulation|September 1, 1990
Circadian variation of acute myocardial infarction and the effect of low-dose aspirin in a randomized trial of physiciansP M Ridker, J E Manson, J E Buring, et al.Lancet (London, England)|April 16, 1994
Prospective study of endogenous tissue plasminogen activator and risk of strokeP M Ridker, C H Hennekens, M J Stampfer, et al.Pageof 42